Danimer Scientific (DNMR) EGM 2024 summary
Event summary combining transcript, slides, and related documents.
EGM 2024 summary
19 Jan, 2026Opening remarks and agenda
Meeting convened to seek stockholder approval for board authority to implement a reverse stock split to maintain NYSE listing.
Only one item of business: approval of an amendment to the Certificate of Incorporation for a reverse stock split.
Specific resolutions to be voted on
Proposal to amend and restate the Certificate of Incorporation to allow a reverse stock split at a ratio between 1-for-20 and 1-for-40, at the board's discretion.
Board recommended stockholders vote in favor; motion and second were made by stockholders.
Board and executive committee updates
Interim CEO introduced board members and executive officers present.
Quorum confirmed with over 68 million shares represented.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Danimer Scientific
- All proposals, including director elections and share increases, were approved by majority vote.DNMR
AGM 20243 Feb 2026 - PHA revenues to more than triple by mid-2025 as cost controls and financing support growth.DNMR
Q2 20242 Feb 2026 - Q3 2024 saw lower sales and ongoing losses, with severe liquidity and debt concerns.DNMR
Q3 202413 Jan 2026